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Abstract
Background. Patients with glioma often suffer from cognitive deficits. Physical exercise has been effective in ameli-
orating cognitive deficits in older adults and neurological patients. This pilot randomized controlled trial (RCT) 
explored the possible impact of an exercise intervention, designed to improve cognitive functioning in glioma pa-
tients, regarding cognitive test performance and patient-reported outcomes (PROs).
Methods. Thirty-four clinically stable patients with World Health Organization grades II/III glioma were randomized to a 
home-based remotely coached exercise group or an active control group. Patients exercised 3 times per week for 20–45 
minutes, with moderate to vigorous intensity, during 6 months. At baseline and immediate follow-up, cognitive perfor-
mance and PROs were assessed with neuropsychological tests and questionnaires, respectively. Linear regression analyses 
were used to estimate effect sizes of potential between-group differences in cognitive performance and PROs at 6 months.
Results. The exercise group (n = 21) had small- to medium-sized better follow-up scores than the control group (n 
= 11) on several measures of attention and information processing speed, verbal memory, and executive function, 
whereas the control group showed a slightly better score on a measure of sustained selective attention. The ex-
ercise group also demonstrated small- to medium-sized better outcomes on measures of self-reported cognitive 
symptoms, fatigue, sleep, mood, and mental health–related quality of life.
Conclusions. This small exploratory RCT in glioma patients provides a proof of concept with respect to improvement 
of cognitive functioning and PROs after aerobic exercise, and warrants larger exercise trials in brain tumor patients.
Key Points
1. Proof of concept: Exercise may improve cognitive function in glioma patients.
2. Exercise may benefit patient-reported outcomes in glioma patients.
3. Larger trials of exercise for cognitive improvement in glioma patients are warranted.
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After initial medical treatment, many patients with lower-
grade glioma at first glance seem to live free from neu-
rological symptoms for years until the disease progresses. 
However, they may suffer from deficits in various cog-
nitive domains, including attention, memory, executive 
functioning, and language, which primarily result from the 
tumor and its treatment.1,2 Although in most cases the cog-
nitive deficits, as determined by neuropsychological tests, 
are mild or moderate, they can substantially impact pa-
tients' lives. In particular during the progression-free period, 
these relatively young patients experience the effects of 
their cognitive impairment when they attempt to resume 
normal family, work, and social activities. Only few studies 
have evaluated interventions aimed at amelioration of cog-
nitive impairment in patients with brain tumors. These have 
included behavioral interventions, such as cognitive rehabil-
itation, and pharmacological approaches.3
Research has indicated that physical exercise can be 
effective in delaying or ameliorating cognitive decline, 
in particular in healthy individuals and those suffering 
from dementia, but also in other patients with neurolog-
ical disorders and, as most recently described, in patients 
with breast cancer.4–7 Several neuroplastic mechanisms 
have been reported to be involved in exercise-related 
improvement (or maintenance) of brain/cognitive func-
tion.4,8,9 These include enhancement of angiogenesis, 
synaptogenesis and neurogenesis, upregulation of neuro-
trophic factors, such as brain-derived neurotrophic factor, 
and anti-inflammatory effects.4,8,9 
Very recently, researchers have begun to explore exer-
cise interventions in single-arm studies with small samples 
of patients with brain tumors. These studies have dem-
onstrated safety and feasibility and have provided indi-
cations of improvements on measures of well-being.10–12 
Interestingly, a recent crossover study on exercise for the 
improvement of neural recovery in 28 pediatric survivors 
of brain tumors demonstrated exercise-related increase of 
white matter integrity and hippocampal volume, and asso-
ciated improvements in reaction time.13
Recently, we published the first findings on feasibility 
and intermediate outcomes in a small pilot randomized 
controlled trial (RCT) of an exercise intervention specifi-
cally aimed at the improvement (or maintenance) of cog-
nitive functions in patients with lower-grade glioma. The 
6-month, home-based intervention, including 3 aerobic 
exercise sessions per week with distant monitoring by a 
physical therapist, was found to be feasible in a group of 
motivated patients.14 Patients adhered, on average, to 79% 
of the prescribed training sessions, and their experiences 
were positive. At 6 months follow-up, the exercise group 
showed larger improvements in aerobic fitness (volume of 
peak oxygen uptake  [VO2 peak]
1: +158.9 mL/min; 95% CI: 
−44.8 to 362.5) compared with the control group.
The study also included a battery of neuropsycholog-
ical tests and patient-reported outcome (PRO) measures. 
Here, we evaluate indications of effects of the program at 
the group and  individual level on cognitive performance 
scores of attention, memory, and executive function and 
at the group level on PROs (cognitive symptoms, fatigue, 
sleep, mood, and quality of life).
Patients and Methods
Study Design
The study was designed as a pilot RCT, in which 60 patients 
would be allocated in a 2:1 ratio to a 6 months of exercise 
intervention or a waiting-list control group. Treatment allo-
cation was done by a computer program (ALEA15), using 
a minimization procedure16 that balanced groups on age 
(<40, 40–50, >50), education (lower, higher), World Health 
Organization (WHO) tumor grade (II, III), disease duration 
(<5, ≥5 y), relative VO2 classification (recreational physical 
activity, sedentary17) and performance on the letter-digit 
substitution task (≤43, >4318). Assessments of cardiores-
piratory fitness, cognitive performance, and PROs were 
conducted before randomization and after 6  months. As 
the objective of this small exploratory study was not to 
test hypotheses, we evaluated effect sizes for group level 
comparisons.
Approval was obtained from the medical ethics committee 
Brabant, Netherlands (file NL44024.008.13). The trial was 
registered with www.clinicaltrials.gov: NCT02303938. All 
patients provided written informed consent.
Importance of the Study
Few efforts have been undertaken to ameliorate the 
cognitive impairment in glioma patients despite patients' 
relatively young age and rather favorable prognosis. 
Physical exercise has been effective in ameliorating 
cognitive deficits in older individuals and neurological 
patients and in improving quality of life of cancer pa-
tients. Therefore, exercise is a promising intervention 
that may address multiple brain cancer symptoms, in-
cluding cognitive impairment. We conducted a small 
RCT of a 6-month home-based remotely coached 
aerobic exercise program that specifically aimed for 
amelioration of cognitive deficits in glioma patients. In 
a previous feasibility evaluation in the sample of motiv-
ated patients, adherence and patient satisfaction were 
good. Although statistical testing was limited by small 
groups, the current study provides a proof of concept 
regarding physical fitness, cognitive test performance 
and cognitive symptoms, fatigue, sleep, mood, and 
quality of life. This study provides practical suggestions 
for future larger exercise trials in brain tumor patients.
1VO2 peak was determined as the highest value of oxygen uptake 
achieved during a maximal incremental cycle ergometer test, and 
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Patients were recruited from September 2013 until 
December 2014 from 3 Dutch hospitals: Elisabeth-
TweeSteden Hospital Tilburg, Haaglanden Medical Center 
The Hague, and Erasmus Medical Center Rotterdam. Based 
on historical patient census data from these centers, we 
anticipated being able to recruit 60 patients into the study 
in the time available.
Adult patients were eligible for participation if they had: 
(i) histologically proven or presumed WHO grade II glioma 
or (ii) anaplastic (grade III) glioma and were clinically 
stable for a minimum of 6 months prior to study entry as 
determined by MRI. Other inclusion criteria were: a self-
reported low or moderate level of physical activity (ie, less 
than 20 minutes of vigorous exercise on fewer than 3 days 
per week), access to the internet, basic fluency in the Dutch 
language, interest to participate in the physical exercise 
program, and a VO2 peak, as assessed with maximal car-
diopulmonary exercise testing (CPET), within the range of 
sedentary or recreationally active reference groups.17
Exclusion criteria were: anti-tumor treatment (ie, sur-
gery, radiotherapy, chemotherapy, corticosteroids) within 
6 months prior to study entry, use of beta-blockers, psy-
chiatric or severe cognitive problems that would preclude 
program participation, and presence of comorbid condi-
tions that contraindicate exercise without face-to face su-
pervision as assessed with the Physical Activity Readiness 
Questionnaire (PAR-Q)19 or as judged by the sports physi-
cian based on CPET.
Procedures
For a detailed description of study procedures, see Gehring 
et  al.14 Briefly, patients who were medically eligible re-
ceived a study information letter from their physician and a 
reply card to indicate permission to be approached by the 
study team. Interested patients received a phone call to ex-
plain study procedures and to screen for physical activity 
level and safety of the exercise. Interested and eligible pa-
tients provided informed consent, underwent neuropsy-
chological assessment (NPA) at their homes, and received 
questionnaires on PROs to be completed and returned by 
mail. Subsequently, patients were invited to undergo CPET 
at one of the 4 sports medical centers involved in the study.
Patients who were eligible according to all criteria were 
randomized and informed about their allocation by phone. 
After 6 months, NPA, PRO assessments, and CPETs were 
repeated. Neither patients nor assessors were blinded 
to group allocation, except for the sports physicians per-
forming the CPETs. The decision to halt participation in 
case of progressive disease was left up to the patient and 
the treating physician.
Physical Exercise Intervention
The home-based, remotely coached intervention com-
prised 3 aerobic training sessions per week for a period 
of 6 months. Based on their baseline level of cardiorespi-
ratory fitness and exercise tolerance, patients received an 
individual home-based exercise prescription regarding 
intensity (60–85% of their maximum heart rate) and du-
ration (20 to 45 minutes) of the training sessions from 
the physical therapist. Exercise duration and intensity 
were progressed over the months. Patients could choose 
one or more activities of their own preference (eg, run-
ning, cycling, swimming) as long as they could meet the 
exercise prescription. During the activities, participants 
wore a training watch with heart rate monitor and Global 
Positioning System. This watch provided immediate feed-
back about heart rate and, if applicable, speed and dis-
tance, and could be connected to an online platform 
recording the activities. The physiotherapist could access 
these data and thereby guide the patients remotely on a 
weekly basis.
Waiting-List Control Condition
Patients in the active control group received a motiva-
tional brochure in the first week after randomization and at 
3 months in which they were advised to maintain an active 
lifestyle in accordance with the Dutch public health guide-
lines.20 They also received bimonthly phone calls during 
which general questions about their health were asked. 
This minimum intervention was intended to provide some 
control for attention effects. After completion of all study 
assessments, patients in the control group were offered a 
training watch and a general exercise prescription.
Outcome Measures
We obtained data on patients' age, sex, and level of edu-
cation via interview and retrieved clinical information from 
medical records. We assessed cognitive performance of 
both study groups at the patients' homes at baseline (NPA1) 
and after 6 months (NPA2) with a battery of neuropsycho-
logical tests of attention, memory, and executive function 
(see Table 1). Subsequently, patients in both groups com-
pleted several PRO questionnaires on cognitive symptoms, 
fatigue, sleep, mood, and health-related and aspects of 
brain cancer–related quality of life (see Table 1).
Statistical Methods
Summary statistics for baseline characteristics with respect 
to sociodemographic and clinical variables, cognitive perfor-
mance, and PROs were calculated for the 2 groups. In order 
to facilitate comparisons of the magnitude of group change 
over time across outcome measures, we standardized all 
NPA and PRO scores by subtracting the total group baseline 
mean score from each patient's individual score and dividing 
this by the total group baseline standard deviation. For this, 
we used “trimmed” means and standard deviations, by recal-
culating the baseline mean and standard deviations, leaving 
out raw scores equating Z scores > |3.29|.39  When needed, we 
recoded scores so that, for all measures, higher Z scores in-
dicate better outcomes. We present changes in Z scores from 
baseline to follow-up for both groups in bar charts.
No a priori level of statistical significance for between-
group differences in outcome was set, as the objective of this 
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Table 1 NPA and PRO measures at baseline and follow-up
Cognitive Performance Measures




Stroop Color-Word Test21–23 SCWT-Int Interference—ratio of the additional time 
needed for Card III relative to Card I (time) 
and II (time)
Attentional inhibition of a 
dominant response
Letter Digit Substitution Test18 LDST-Read 90 Sec Reading (number correct: 0–125) Information processing speed
LDST-Write 90 Sec Writing (number correct: 0–125) Psychomotor and information 
processing speed
WAIS-R Digit span24,25 DS-Forw Forward (span: 0–8) Attention span
DS-Backw Backward (span: 0–7) Working memory
Test of Everyday Attention26 ElevCount-Distr Elevator counting with Distraction 
(number correct: 0–10)
Auditory selective attention 
and working memory
TelSearch Telephone Search task (time per target: 
0–∞)
Sustained selective attention
TelSearch-Count Telephone Search while Counting (decre-
ment in speed due to 2nd task)
Divided attention
Memory
Visual Verbal Learning Test27 VVLT-T1 Trial 1 (number correct: 0–15) Immediate verbal recall
VVLT-Tot Total (number correct: 0–75) Verbal learning
VVLT-DelRec Delayed Recall (number correct: 0–15) Delayed verbal memory
WMS-III Verbal Paired Asso-
ciates24
VPA-DiRecA Direct Recall List A (number correct: 0–8) Immediate verbal association 
memory
VPA-TotRec Total Recall (number correct: 0–32) Verbal association learning
VPA-DelRec Delayed Recall (number correct: 0–8) Delayed verbal association 
memory
Executive function
Concept Shifting Test28,29 CST-Shift Additional time needed for CST-C above 
CST-A and CST-B 
Alternating attention/shifting
GIT Letter Fluency25 GIT-LF LF (number correct: 0-∞) Speed and flexibility of verbal 
thought process
GIT Category Fluency30 GIT-CF CF (number correct: 0-∞) Speed and flexibility of verbal 
thought process and applica-
tion of strategies




Patient-reported outcome measures 
Questionnaire    
Subjective cognitive functioning
MOS Cognitive Functioning 
Scale31
CFS total Total score (6–30) Subjective cognitive function
Cognitive Failure Question-
naire32,33
CFQ total Total score (0–100) Subjective cognitive failures in 
daily life
Subjective fatigue and sleep
Multidimensional Fatigue 
Inventory34
MFI-GF General Fatigue (4–20) General fatigue
MVI-PF Physical Fatigue (4–20) Physical fatigue
MVI-RA Reduced Activity (4–20) Reduced activity
MVI-RM Reduced Motivation (4–20) Reduced motivation
MVI-MF Mental Fatigue (4–20) Mental fatigue
Pittsburgh Sleep Quality 
Index35
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Table 1 Continued
not to test a prespecified hypothesis. Instead, we present 95% 
confidence intervals (CIs) around estimates to indicate their 
precision and effect sizes for all group level comparisons. 
SPSS v24.0.0.0 was used for all group level comparisons.
Analyses of between-group differences in cognitive 
performance and PROs
As the primary approach to assessing potential interven-
tion effects, we used linear regression analyses for all NPA 
and PRO scores at 6  months, including baseline scores 
as covariates. When an extreme baseline or follow-up Z 
score (Z  >  |3.29|) resulted in violation of an assumption, 
the outlier score was replaced by the less extreme value of 
|3.29|.39 If the subsequent model met its assumptions, this 
value was used in the group level analyses.
Due to the standardization of scores, the beta coefficients 
of the regression analyses (ie, the between-group differ-
ences in outcome) are equal to Glass's delta effect sizes. 
Effect sizes ≥0.2 were considered small, between 0.50 and 
0.79 medium, and ≥0.8 large. Results are reported in the 
text when effect sizes were ≥0.2.
Analyses of individual reliable cognitive change
Reliable change indices (RCIs) for all individual pa-
tients were calculated for changes in all NPA raw scores. 
A  regression-based RCI40 was employed, which takes 
common methodological confounds resulting from re-
peated neuropsychological testing into account, such as 
practice effects and imperfect test-retest reliabilities. We 
used neuropsychological data from the non-intervention 
control group from our previous RCT on cognitive re-
habilitation to determine practice effects and test-retest 
reliabilities41,42 for the interval from baseline to about 
8  months follow-up. This non-intervention control group 
included 63 cross-sectionally recruited low-grade and 
anaplastic glioma patients. Extreme individual scores of 
patients from the current study were not replaced by alter-
native values in the calculations of their RCIs.
Individual change was defined by RCI values exceeding 
±1.645 (corresponding with a 90% CI). The numbers of pa-
tients with reliably improved, declined, or nonchanged per-
formance were compared between groups for each NPA 
variable. Standardized residuals were calculated, whereby 
values exceeding ±1.5 were used as cutoff for dispropor-
tionate distributions.
Results
Patient Recruitment and Retention
Thirty-four of 136 invited patients (25%) were recruited and 
allocated to the exercise (N  = 23) or the control (N  = 11) 
group. Fig. 1 displays detailed information on recruitment 
and retention. A more detailed description of reasons for 
non-participation can be found in Gehring et al.14
Two patients dropped out of the exercise group. There 
was no attrition in the control group before NPA2. In addi-
tion, one exercise group patient did not return self-report 
questionnaires. All control group patients returned com-
pleted questionnaires.
Baseline Characteristics
The patients in the intervention group (n = 21) and control 
group (n =  11) with complete NPA1 and NPA2 data were 
comparable with respect to baseline sociodemographic, 
Mood
Profile of Mood States36 POMS total Total score (22–120) Mood
Quality of life
Brain-cancer specific HRQL 
questionnaire37
QLQ-BN20 FU Future Uncertainty (0–12) Brain-cancer specific future 
uncertainty
QLQ-BN20 VD Visual Disorder (0–9) Brain-cancer specific visual 
disorder
 QLQ-BN20 MD Motor Dysfunction (0–9) Brain-cancer specific motor 
dysfunction
 QLQ-BN20 CD Communication Deficit (0–9) Brain-cancer specific  
communication deficit
MOS Short-Form 3638 SF-36 PCS Physical Component Scale (0–100) Mental health–related quality 
of life
SF-36 MCS Mental Component Scale (0–100) Physical health–related quality 
of life
∞: no upper limit. 
Abbreviations: GIT, Groningen Intelligence Test. HRQL, health-related quality of life. MOS, Medical Outcomes Study. WAIS-R, Wechsler Adult 
Intelligence Scale–Revised. WMS-III, Wechsler Memory Scale III. 
  
Patient-reported outcome measures 
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clinical, and physical fitness characteristics (Table 2). As 
the exercise group dropouts included one patient with a 
grade II and one with a grade III astrocytoma, there was 
a slightly higher proportion of grade II astrocytoma in the 
final intervention group. For a small majority of cognitive 
tests, performance at baseline was somewhat better for 
the exercise group, while baseline PRO scores were some-








NPA1 (N = 43)
CPET1 (N = 36)
Minimisation (N = 34)
Training group (N = 23)
6 months
1–2 weeks
Lost to follow-up (N = 2)
Progressive disease: N = 1
Lack of motivation: N = 1
Lost to follow-up (N = 2)
Progressive disease: N = 1
Training program too
intensive: N = 1
Excluded (N = 7)
Progressive disease: N = 5
Excellent cognitive performance: N = 1
Cancelled participation because too
burdensome: N = 1
Excluded (N = 66)
Reply card (no reason reported): N = 18
No response: N = 8
Inaccessible: N = 4
No time: N = 18
Lack of exercise motivation: N = 6
Physical limitations: N = 4
Lack of basic proficiency in Dutch: N = 2
No cognitive complaints: N = 2
Progressive disease: N = 2
Other: N = 2
Excluded by doctor (N = 17)
Treatment elsewhere: N = 4
Neurological disorder: N = 3
Psychologically unstable: N = 2
Recent diagnosis of grade IV glioma:
N = 1
Recent chemotherapy treatment: N = 1
Recently deceased: N = 1
Other: N = 5
Excluded (N = 27)
> 20 minutes exercise on at least 3
days: N = 14
No time: N = 2
Lack of exercise motivation: N = 2
Unable to exercise intensively: N = 4
Use of adrenergic beta-blocker: N = 2
Psychologically unstable: N = 1
Progressive disease: N = 1
Unknown: N = 1
Excluded (N = 2)
Electrocardiogram deviation: N = 1
Withdrawn from participation: pt
preferred training with face-to-face
supervision: N = 1
Lost to follow-up (N = 0)
Lost to follow-up (N = 2)
Psychologically unstable: N = 1
Lack of motivation: N = 1
Control group (N = 11)
NPA2 (N = 32)
Training group (N = 21) Control group (N = 11)
CPET2 (N = 28)
Training group (N = 19) Control group (N = 9)
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Results of Analyses of Between-Group 
Differences in Cognitive Performance
One patient in the control group had an extremely low Z 
score for baseline TelSearch and another patient in this 
group for follow-up CST-Shift, resulting in violation of the 
regression assumptions. These scores were replaced by 
−3.29, which resolved the issue.
Fig. 2 displays within-group Z score changes in bar 
charts. Mean or median baseline and follow-up standard-
ized scores, within-group changes therein, and 95% CIs can 
be found in Supplementary Table 1. Table 3 shows that, for 
attention, the exercise group had higher follow-up scores 
than the control group on measures of attentional inhibi-
tion (SCWT-Int), of attention span (DS-Forw) and of auditory 
selective attention and working memory (ElevCount-Distr), 
both with a medium effect size. In addition, the exercise 
group performed slightly better than the control group on 
a measure of information processing speed (LDST-Read). 
However, we also observed a small benefit for the con-
trol group on a measure of sustained selective attention 
(TelSearch). For memory, there was a small difference in 
favor of the exercise group for immediate verbal recall 
(VVLT-T1). Finally, the exercise group had higher follow-up 
scores on 2 measures of executive function: auditory 
working memory (ElevCount-Rev) and alternating attention 
(CST-Shift), with small effect sizes.
Individual Change in Cognitive Performance 
Over Time
For a measure of auditory selective attention and working 
memory (ElevCount-Distr) and for a measure of atten-
tional inhibition (SCWT-Int), disproportionally more pa-
tients with reliably declined scores (RCIs < −1.645) were 
found in the control group than in the exercise group (see 
Supplementary Table 2). However, for the measure of sus-
tained selective attention [TelSearch], fewer patients de-
clined in the control group (including one patient with the 
extremely low baseline score) than in the exercise group.
Five (24%) participants in the exercise group versus 2 (18%) 
in the control group showed a reliable improvement on 2 or 
more cognitive measures (see Table 4). A reliable decline on 2 
or more measures was observed for 4 (19%) exercise group 
participants, versus 3 (27%) control group participants.
  
Table 2 Baseline characteristics of participants with complete NPA1 and NPA2 data
Characteristic Exercise Group (N = 21) Control Group (N = 11)
Age, y   
 mean (SD) 49.2 (8.9) 48.0 (11.9)
Female, n (%) 12 (57) 6 (55)
Education, n (%)   
 low 2 (10) 0 (0)
 middle 9 (43) 6 (55)
 high 10 (47) 5 (46)
WHO tumor grade, n (%)   
 II 15 (71) 6 (55)
 III 6 (29) 5 (46)
Tumor histology, n (%)   
 astrocytoma 6 (29) 5 (46)
 oligodendroglioma 12 (57) 5 (46)
 oligoastrocytoma 3 (14) 1 (9)
Disease duration, y 7.6 (5.0) 8.5 (8.6)
 mean (SD)
Left hemisphere, n (%) 10 (48) 4 (36)
Surgery, n (%)   
 biopsy 2 (10) 1 (9)
 resection 19 (90) 9 (82)
Chemotherapy, n (%) 8 (38) 4 (36)
Radiotherapy, n (%) 12 (57) 5 (46)
Epilepsy, n (%) 15 (71) 8 (73)
Anti-epileptic drugs, n (%) 12 (57) 6 (55)
VO2 peak classification,
17 n (%)   
 recreational (versus sedentary) 4 (19) 1 (9)
LDST-Write,18 number correct, mean 
(SD) 
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Results of Analyses of Between-Group 
Differences in PROs
Fig. 2 displays within-group changes of Z scores in bar 
charts. Mean or median baseline and follow-up standard-
ized scores, within-group changes therein, and 95% CIs are 
shown in Supplementary Table 1.
Post-intervention, the exercise group had higher out-
comes than the control group on 1 of 2 measures of self-
reported cognitive functioning (CFS total), with a small 
effect size (Table 3). We also observed a small benefit for 
sleep (PSQI total) and less fatigue with respect to 2 scales 
(Physical fatigue and Reduced activity) of medium effect 
size, for the exercise group. Finally, patients reported 
better mood (POMS total) and mental health–related 
quality of life (SF36 MCS) in the exercise group versus 
the control group, both with a medium effect size. We ob-
served no between-group differences for the brain cancer 
specific health-related quality of life scales (QLQ BN-20 
FU, VD, MD, and CD).
  
Table 3 Between-group effects on NPA and PRO measures
Cognitive Performance  
Measures
B [95% CI] Patient-Reported Outcomes B [95% CI]
Exercise Group n = 21 Exercise Group n = 20
Control Group n = 11 Control Group n = 11
Attention  Self-reported cognitive functioning
SCWT-Int +0.52 [0.05;0.99] CFS total +0.20 [−0.45;0.86]
LDST-Read +0.47 [−0.16;1.10] CFQ total +0.04 [−0.52;0.60]
LDST-Write +0.18 [−0.20;0.56] Fatigue and sleep  
DS-Forw +0.57 [−0.01;1.14] MFI−GF +0.14 [−0.43;0.71]
DS-Backw −0.04 [−0.89;0.81] MFI−PF +0.52 [−0.23;1.27]
ElevCount-Distr +0.51 [0.03;0.98] MFI−RA +0.63 [−0.17;1.43]
TelSearch −0.47 [−1.43;0.49] MFI−RM +0.19 [−0.51;0.89]
TelSearch-Count −0.13 [−0.81;0.55] MFI−MF 0.00 [−0.57;0.56]
Memory  PSQI total +0.34 [−0.23;0.91]
VVLT-T1 +0.29 [−0.56;1.13] Mood  
VVLT-Tot +0.16 [−0.42;0.74] POMS total +0.50 [0.04;0.96]
VVLT-DelRec +0.11 [−0.49;0.71] Quality of life  
VPA-DiRecA −0.02 [−1.13;1.10]   
VPA-TotRec +0.13 [−0.35;0.62] SF36 PCS −0.18 [−0.86;0.49]
VPA-DelRec +0.14 [−0.20;0.48] SF36 MCS +0.63 [−0.16;1.41]
Executive function  QLQ−BN20 FU +0.08 [−0.52; 0.68]
CST-Shift +0.35 [−0.30;0.99] QLQ−BN20 VD +0.19 [−0.27; 0.66]
GIT-LF −0.13 [−0.61;0.35] QLQ−BN20 MD +0.14 [−0.30; 0.59]
GIT-CF +0.07 [−0.45;0.59] QLQ−BN20 CD −0.01 [−0.46; 0.45]
ElevCount-Rev +0.25 [−0.23;0.73]   
Abbreviations: B, regression coefficient. CI, confidence interval.
  
  
Table 4 Numbers of tests with reliably improved and reliably declined individuals in each group
Reliable Improvement Reliable Decline
Exercise Group Control Group Exercise Group Control Group
Number of test variables (standardized resid-
uals)
0 9 (−0.3) 6 (0.4) 12 (0.7) 3 (−0.9)
1 7 (0.2) 3 (−0.2) 5 (−0.6) 5 (0.8)
2 1 (−0.7) 2 (1.0) 4 (0.0) 2 (0.0)
3 2 (0.6) 0 (−0.8) 0 (−0.8) 1 (1.1)
4 1 (0.4) 0 (−0.6) – –
5 1 (0.4) 0 (−0.6) – –
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Discussion
We conducted a pilot RCT of a 6-month, home-based, re-
motely coached aerobic exercise program intended to 
ameliorate cognitive impairment in patients with stable 
grades II and III glioma. Thirty-four patients were random-
ized to the exercise group or to the control group. In our 
first report on the feasibility of this program,14 we con-
cluded that recruitment was challenging and time-con-
suming but that adherence, safety, and patient satisfaction 
were good. In addition, physical fitness, as measured with 
maximum exercise testing, improved in the exercise group 
but not in the control group.
Here, we evaluated indications of effects of the program 
on cognitive test performance and PROs. Although, at the 
group level, the results suggested trends toward better 
cognitive performance after exercise, at the individual 
level these changes did not always reach our rather strin-
gent cutoffs for reliable change. Despite this, trends sup-
porting further exploration of exercise interventions in 
patients with glioma are clearly present.
In this sample, for most cognitive measures, between-
group differences at follow-up, after correction for base-
line cognitive performance, favored the exercise group. 
Patients in the exercise group had higher scores than those 
in the control group on a measure of attentional inhibition, 
of attention span, and of auditory selective attention and 
working memory, each with a medium effect size. In addi-
tion, small differences in favor of the exercise group were 
observed for a measure of information processing speed 
and of immediate verbal recall, and for 2 measures of exec-
utive function: auditory working memory and alternating 
attention/shifting. However, we also observed a small ben-
efit for the control group on a measure of sustained selec-
tive attention.
The cognitive benefits of exercise were mostly observed 
for measures with a clear component of information proc-
essing speed and working memory, functions that are 
important for everyday mental operations, such as cal-
culating, reasoning, and decision making. These findings 
are consistent with the literature on cognitive effects of 
exercise in other patient populations, in which effects on 
global or multiple domains of cognitive function have been 
reported most frequently.43,44 However, in studies that 
evaluated effects on separate cognitive domains, bene-
fits for attention and executive function are most often 
reported.9,43
The individual-level findings (somewhat more patients 
who declined on a measure of attentional inhibition and 
of auditory selective attention and working memory, and 
fewer patients who declined on a measure of sustained 
selective attention [or vigilance] in the control group com-
pared with the intervention group) were consistent with 
the group-level findings for these measures. One expla-
nation for the observed benefit for the control group on 
sustained selective attention may be that exercise reduces 
participants' arousal levels, resulting in lower vigilance, as 
has been reported in a previous small trial in patients with 
insomnia.45 It may also be an effect of the advice to main-
tain an active lifestyle, or it could be a chance finding.
Overall, at the individual level, only a few patients ap-
peared to improve reliably over time, although improve-
ments occurred slightly more frequently in the exercise 
group. At the same time, individual cognitive decline oc-
curred rather frequently in both groups. The criteria for in-
dividual reliable change were based on a control group of 
patients who were somewhat younger and for whom data 
from a third assessment were used,41 and therefore prac-
tice effects in that previous group may have been larger. 
In that case, the number of improved and declined individ-
uals in the current sample may have been underestimated.
With respect to the PROs, analyses suggested consistent 
between-group differences in favor of the exercise group. 
At 6 months, these patients reported less physical fatigue 
and less reduced activity, and better mood and mental 
health–related quality of life, all of medium effect size. 
In addition, we observed small effects for sleep and self-
reported cognitive functioning. No substantial differences 
were observed for general fatigue, mental fatigue, and re-
duced motivation or for brain cancer specific and physical 
health–related quality of life.
We would emphasize that, due to the small sample size in 
this exploratory trial, the results are tentative and sugges-
tive only. As this was one of the first studies in this area, we 
included many outcome measures to estimate potential ef-
fects for the multitude of symptoms that patients with brain 
tumors face. The combination of many outcome measures 
and small groups—in which we observed some extreme 
values—increases the likelihood of chance findings related 
to sample idiosyncrasies. After 2 dropouts, the proportion 
of patients with grade III glioma in the exercise group was 
somewhat smaller (29%) than in the control group (46%) at 
the 6-month timepoint. Therefore, neuropsychological im-
provements over time in the intervention group could have 
been affected, in part, by the slightly higher proportion of 
grade II patients.
The sample we were able to include was smaller than 
we had anticipated. This was due to a combination of strin-
gent selection criteria and low uptake (25% of eligible 
patients).14 During recruitment, many eligible patients 
reported a lack of time or motivation to participate in the 
trial and/or training program. Consequently, the sample 
consisted of a motivated group of patients for whom an in-
tensive exercise program may be particularly feasible. This 
suggests that the intervention, in its current form, may be 
of interest and benefit to a relatively small subset of the 
target population.
A strength of the study was the careful consideration 
of the exercise parameters, based on previous research 
in other populations indicating that the cognitive bene-
fits of exercise, and the underlying biological mechan-
isms in terms of enhanced angiogenesis, upregulation of 
neurotrophins, and increased neurogenesis, may be more 
strongly related to aerobic training versus other types of 
exercise, such as resistance training (only).9,44 Given this 
rationale, we considered cardiorespiratory fitness as an 
intermediate endpoint to determine feasibility of an exer-
cise program specifically designed to improve cognitive 
function. The setup of our exercise program (ie, 3 aerobic 
training sessions of 20 to 45 minutes at 60‒85% of the max-
imum heart rate per week during 6 months) resulted in in-
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improvements, which is consistent with the conceptual 
working mechanism of our exercise intervention. A draw-
back of this rather intensive exercise regimen, however, is 
that during the study's recruitment phase it may have been 
perceived as too intimidating for less motivated patients. 
Among the motivated group of participants we included, 
17 reported a willingness to continue to exercise, of whom 
9 indicated the intention to decrease the frequency to 1 or 
2 training sessions per week. It is unclear whether a lower-
frequency regimen would yield or maintain acceptable ef-
fects on physical and cognitive measures and/or PROs.
To conclude, 6  months of home-based, remotely 
coached exercise is feasible in terms of adherence, safety, 
and patient satisfaction in a select group of motivated 
stable glioma patients, and exercise may improve their 
cardiorespiratory fitness.14 Small to medium effects were 
also observed for several cognitive performance measures 
of attention, memory, and executive function and for self-
reported cognitive functioning, fatigue, sleep, mood, and 
quality of life.
Although the performance of this trial required much 
effort and did not demonstrate clear cognitive effects 
of exercise for individual patients, we believe that con-
ducting follow-up research would be worth the effort. 
Patients with brain tumors are known to have consider-
ably reduced physical fitness.46 Recently, Cormie and col-
leagues provided a strong theoretical rationale, based on 
evidence from other cancer and chronic disease popula-
tions, for the potential beneficial effects of exercise on the 
physical, cognitive, and psychological symptoms related 
to brain cancer and its treatment.12 In addition, exercise 
may be beneficial in terms of reducing seizure suscepti-
bility.47 If exercise aids in the management of multiple 
brain cancer symptoms, this may be a relatively inexpen-
sive intervention.12 Appropriately designed, well-executed 
RCTs are needed to demonstrate whether (home-based, 
remotely coached) exercise interventions are (cost) ef-
fective in reducing a range of symptoms and functional 
limitations, with very few adverse effects, in patients with 
brain cancer.
These studies especially need larger samples to obtain 
sufficient power to perform formal hypothesis tests, and to 
detect small to medium effects on physical and cognitive 
measures and PROs. However, recruitment of large sam-
ples will be a challenge. Therefore, sufficient time should 
be allocated, and involvement of a relatively large number 
of study centers may be necessary. Studies offering a pro-
gram with a lower frequency of exercise sessions per week 
might have a higher uptake. During such a program, the fre-
quency could be increased for patients who are able and 
willing to meet the exercise recommendation for cancer 
survivors.48 Although brain tumor patients generally report 
a preference for home-based exercise,49,50 4 patients in our 
sample indicated preferring face-to-face or group training.14 
Offering patients the choice of home-based training, face-
to-face supervision, and/or group training in a physical 
therapy center may further increase uptake. Furthermore, 
combining physical training with (simultaneous) cognitive 
training with gaming elements may be more attractive for 
patients to attend to, and at the same time have stronger 
cognitive effects.8 The larger samples that may be obtained 
in these ways may facilitate determining which specific pa-
tients would benefit most from exercise interventions. In 
addition, dose-response relationships should be examined 
to determine a minimal effective dose. Including a long-
term follow-up assessment could provide information on 
the maintenance of exercise behavior and the benefits of 
exercise. Furthermore, future studies could include inflam-
matory markers or measures of neurotrophic factors such 
as brain-derived neurotrophic factor to determine biolog-
ical mechanisms of the potential relationship between ex-
ercise and cognitive function in patients with brain tumors.
Supplementary Material
Supplementary data are available online at Neuro-
Oncology (http://neuro-oncology.oxfordjournals.org/).
Keywords
brain neoplasms | cognitive function | exercise | glioma | 
patient reported outcome measures
Funding
This research was supported by the Dutch Cancer Society 
(UvT2010-4642).
Conflict of interest statement. The author(s) indicated no 
potential conflicts of interest.
Authorship statement. Conception and design: KG, MSt, CK, 
MT, NA, MSi. Provision of study materials or patients: CT, MB, 
MH, GR, MT. Collection and assembly of data: KG, EV, CK. Data 
analysis and interpretation: KG, MSt, EV, CK, CT, MB, MH, GR, 
MT, NA, MSi. Manuscript writing: KG, MSt, EV, CK, MB, MH, CT, 
GR, MT, NA, MSi. Final approval of manuscript: KG, MSt, EV, CK, 
MB, MH, CT, GR, MT, NA, MSi.
Acknowledgments
We thank our research assistants Fleur Franken, Sophie van 
der Linden, Wietske Schimmel, Eline Verhaak, Karin Eichhorn, 
and Fleur Kuipers, and the Sports Medical Centers from Amphia 
Hospital Breda, Elkerliek Hospital Helmond, Jeroen Bosch 
Hospital Den Bosch, Maxima Medical Center Eindhoven, 








niversiteit van Tilburg user on 13 January 2020
 114 Gehring et al. Exercise for cognitive improvement in glioma patients
References
1. Tucha  O, Smely  C, Preier  M, Lange  KW. Cognitive deficits be-
fore treatment among patients with brain tumors. Neurosurgery. 
2000;47(2):324–333.
2. Laack NN, Brown PD, Ivnik RJ, et al; North Central Cancer Treatment 
Group. Cognitive function after radiotherapy for supratentorial low-
grade glioma: a North Central Cancer Treatment Group prospective 
study. Int J Radiat Oncol Biol Phys. 2005;63(4):1175–1183.
3. van Lonkhuizen PJC, Klaver KM, Wefel JS, Sitskoorn MM, Schagen SB, 
Gehring  K. Interventions for cognitive problems in adults with brain 
cancer: a narrative review. Eur J Cancer Care (Engl). 2019;28(3):e13088.
4. Cotman  CW, Berchtold  NC, Christie  LA. Exercise builds brain health: 
key roles of growth factor cascades and inflammation. Trends Neurosci. 
2007;30(9):464–472.
5. McDonnell MN, Smith AE, Mackintosh SF. Aerobic exercise to improve 
cognitive function in adults with neurological disorders: a systematic re-
view. Arch Phys Med Rehabil. 2011;92(7):1044–1052.
6. Cumming TB, Tyedin K, Churilov L, Morris ME, Bernhardt J. The effect of 
physical activity on cognitive function after stroke: a systematic review. 
Int Psychogeriatr. 2012;24(4):557–567.
7. Campbell KL, Kam JWY, Neil-Sztramko SE, et al. Effect of aerobic exer-
cise on cancer-associated cognitive impairment: a proof-of-concept RCT. 
Psychooncology. 2018;27(1):53–60.
8. Fabel K, Kempermann G. Physical activity and the regulation of neurogen-
esis in the adult and aging brain. Neuromolecular Med. 2008;10(2):59–66.
9. Stimpson NJ, Davison G, Javadi AH. Joggin' the noggin: towards a phys-
iological understanding of exercise-induced cognitive benefits. Neurosci 
Biobehav Rev. 2018;88:177–186.
10. Baima J, Omer ZB, Varlotto J, Yunus S. Compliance and safety of a novel 
home exercise program for patients with high-grade brain tumors, a pro-
spective observational study. Support Care Cancer. 2017;25(9):2809–2814.
11. Capozzi  LC, Boldt  KR, Easaw  J, Bultz  B, Culos-Reed  SN. Evaluating a 
12-week exercise program for brain cancer patients. Psychooncology. 
2016;25(3):354–358.
12. Cormie P, Nowak AK, Chambers SK, Galvão DA, Newton RU. The poten-
tial role of exercise in neuro-oncology. Front Oncol. 2015;5:85.
13. Riggs  L, Piscione  J, Laughlin  S, et  al. Exercise training for neural re-
covery in a restricted sample of pediatric brain tumor survivors: a con-
trolled clinical trial with crossover of training versus no training. Neuro 
Oncol. 2017;19(3):440–450.
14. Gehring K, Kloek CJ, Aaronson NK, et al. Feasibility of a home-based 
exercise intervention with remote guidance for patients with stable 
grade II and III gliomas: a pilot randomized controlled trial. Clin Rehabil. 
2018;32(3):352–366.
15. ALEA. ALEA AVL. https://prod.tenalea.net/avl/dm/. Accessed 30 August 
2019.
16. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of 
minimization for allocation to clinical trials. a review. Control Clin Trials. 
2002;23(6):662–674.
17. Vos  JA. Ergometrie en Trainingsbegeleiding [Ergometry and Training 
Supervision]. 7th ed. Otterlo, Netherlands: Author; 2013.
18. Jolles  J, Houx  PJ, Van  Boxtel  MPJ, Ponds  RWHM. Maastricht Aging 
Study: Determinants of Cognitive Aging. Maastricht, Netherlands: 
Neuropsych Publishers; 1995.
19. Thomas  S, Reading  J, Shephard  RJ. Revision of the Physical Activity 
Readiness Questionnaire (PAR-Q). Can J Sport Sci. 1992;17(4):338–345.
20. Kemper  HGC, Ooijendijk  WTM, Stiggelbout  M. Consensus over 
de Nederlandse Norm voor Gezond Bewegen [Consensus on 
the Dutch standard for healthy exercise]. TSG: Tijdschrift voor 
gezondheidswetenschappen. 2000; 78(3):180–183.
21. Stroop  JR. Studies of interference in serial verbal reactions. J Exp 
Psychol. 1935; 18(6):643–662.
22. Hammes J. De Stroop Kleur-Woord Test: Handleiding [The Stroop Color-
Word Test: Manual]. Amsterdam, Netherlands: Harcourt; 1971.
23. Houx  PJ, Jolles  J, Vreeling  FW. Stroop interference: aging ef-
fects assessed with the Stroop Color-Word Test. Exp Aging Res. 
1993;19(3):209–224.
24. Wechsler  D. WAIS-R Manual. New York, NY: The Psychological 
Corporation; 1981.
25. Lezak  MD, Howieson  DB, Loring  DW, Hannay  HJ, Fischer  JS. 
Neuropsychological Assessment. 4th ed. New York, NY: Oxford 
University Press; 2004.
26. Robertson IH, Ward T, Ridgeway V, Nimmo-Smith I. The Test of Everyday 
Attention. Bury St Edmunds, UK: Thames Valley Test Company; 1994.
27. Brand  N, Jolles  J. Learning and retrieval rate of words presented 
auditorily and visually. J Gen Psychol. 1985;112(2):201–210.
28. Vink M, Jolles J. A new version of the trail-making test as an informa-
tion processing task. J Clin Neuropsychol. 1985; 7:162.
29. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. The concept 
shifting test: adult normative data. Psychol Assess. 2006;18(4):424–432.
30. Luteijn  F, Van  der  Ploeg  FAE. Handleiding Groninger Intelligentie Test 
(GIT). Lisse, Netherlands: Swets and Zeitlinger; 1983.
31. Stewart AL, Ware JE, Sherbourne CD, Wells KB. Psychological Distress/
Well-Being and Cognitive Functioning Measures. Measuring Functioning 
and Well-Being: The Medical Outcomes Study Approach. Durham, NC: 
Duke University; 1992:102–142.
32. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures 
Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(Pt 1):1–16.
33. Ponds  RWHM, Rozendaal  N, Jolles  J. The Cognitive Failure 
Questionnaire: Factor Structure, Effects of Age, Sex and Education and 
the Relation with Cognitive Performance and Psychosocial Variables. 
Maastricht, Netherlands: Neuropsych Publishers; 1999.
34. Smets  EM, Garssen  B, Bonke  B, De  Haes  JC. The Multidimensional 
Fatigue Inventory (MFI) psychometric qualities of an instrument to as-
sess fatigue. J Psychosom Res. 1995;39(3):315–325.
35. Buysse  DJ, Reynolds  CF 3rd, Monk  TH, Berman  SR, Kupfer  DJ. The 
Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice 
and research. Psychiatry Res. 1989;28(2):193–213.
36. Curran  SL, Andrykowski  MA, Studts  MA, Jamie  L. Short form of the 
Profile of Mood States (POMS-SF): psychometric information. Psychol 
Assess. 1995; 7(1):80–83.
37. Osoba D, Aaronson NK, Muller M, et al. The development and psycho-
metric validation of a brain cancer quality-of-life questionnaire for use in 
combination with general cancer-specific questionnaires. Qual Life Res. 
1996;5(1):139–150.
38. Ware  JE Jr, Sherbourne  CD. The MOS 36-item short-form health 
survey (SF-36). I. Conceptual framework and item selection. Med Care. 
1992;30(6):473–483.
39. Field A. Discovering Statistics Using SPSS. 2nd ed. Thousand Oaks, CA: 
Sage Publications, Inc; 2005.
40. Maassen  GH, Bossema  E, Brand  N. Reliable change and practice ef-
fects: outcomes of various indices compared. J Clin Exp Neuropsychol. 
2009;31(3):339–352.
41. Gehring  K, Aaronson  NK, Gundy  CM, Taphoorn  MJ, Sitskoorn  MM. 
Predictors of neuropsychological improvement following cognitive rehabili-
tation in patients with gliomas. J Int Neuropsychol Soc. 2011;17(2):256–266.
42. Rijnen SJM, van der Linden SD, Emons WHM, Sitskoorn MM, Gehring K. Test-
retest reliability and practice effects of a computerized neuropsychological bat-







niversiteit van Tilburg user on 13 January 2020








43. Gomes-Osman J, Cabral DF, Morris TP, et al. Exercise for cognitive brain 
health in aging: A systematic review for an evaluation of dose. Neurol 
Clin Pract. 2018;8(3):257–265.
44. Song D, Yu DSF, Li PWC, Lei Y. The effectiveness of physical exercise on cogni-
tive and psychological outcomes in individuals with mild cognitive impairment: 
a systematic review and meta-analysis. Int J Nurs Stud. 2018;79:155–164.
45. Hartescu I, Morgan K, Stevinson CD. Psychomotor performance decre-
ments following a successful physical activity intervention for insomnia. 
Behav Sleep Med. 2019:1–11.
46. Jones  LW, Cohen  RR, Mabe  SK, et  al. Assessment of physical 
functioning in recurrent glioma: preliminary comparison of per-
formance status to functional capacity testing. J Neurooncol. 
2009;94(1):79–85.
47. Pimentel J, Tojal R, Morgado J. Epilepsy and physical exercise. Seizure. 
2015;25:87–94.
48. Schmitz  KH, Courneya  KS, Matthews  C, et  al; American College of 
Sports Medicine. American College of Sports Medicine roundtable 
on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 
2010;42(7):1409–1426.
49. Jones  LW, Guill  B, Keir  ST, et  al. Exercise interest and preferences 
among patients diagnosed with primary brain cancer. Support Care 
Cancer. 2007;15(1):47–55.
50. Nicole Culos-Reed S, Leach HJ, Capozzi LC, Easaw J, Eves N, Millet GY. 
Exercise preferences and associations between fitness parameters, 
physical activity, and quality of life in high-grade glioma patients. 







niversiteit van Tilburg user on 13 January 2020
